SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No.1)*
ENZON PHARMACEUTICALS INC
___________________________________________________________
(Name of Issuer)
COMMON STOCK
___________________________________________________________
(Title of Class of Securities)
293904108
______________________________
(CUSIP Number)
December 31, 2009
___________________________________________________________
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the Rule pursuant to which this Schedule is filed:
[X] Rule 13d – 1(b)
[ ] Rule 13d – 1(c)
[ ] Rule 13d – 1(d)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)
|
CUSIP No 293904108 |
13G |
Page 2 of 14 Pages |
|
1 |
NAMES OF REPORTING PERSONS Bank of America Corporation 56-0906609 |
|||
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] |
|||
|
3 |
SEC USE ONLY |
|||
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER |
0 |
||
|
6 SHARED VOTING POWER |
2,479,993 |
|||
|
7 SOLE DISPOSITIVE POWER |
0 |
|||
|
8 SHARED DISPOSITIVE POWER |
2,478,396 |
|||
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,479,993 |
|||
|
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] |
|||
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.5% |
|||
|
12 |
TYPE OF REPORTING PERSON (See Instructions) HC |
|||
|
CUSIP No 293904108 |
13G |
Page 3 of 14 Pages |
|
1 |
NAMES OF REPORTING PERSONS |
|||
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] |
|||
|
3 |
SEC USE ONLY |
|||
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION United States |
|||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER |
118 |
||
|
6 SHARED VOTING POWER |
5,393 |
|||
|
7 SOLE DISPOSITIVE POWER |
118 |
|||
|
8 SHARED DISPOSITIVE POWER |
3,796 |
|||
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,511 |
|||
|
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] |
|||
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% |
|||
|
12 |
TYPE OF REPORTING PERSON (See Instructions) BK |
|||
|
CUSIP No 293904108 |
13G |
Page 4 of 14 Pages |
|
1 |
NAMES OF REPORTING PERSONS |
|||
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] |
|||
|
3 |
SEC USE ONLY |
|||
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER |
3,790 |
||
|
6 SHARED VOTING POWER |
0 |
|||
|
7 SOLE DISPOSITIVE POWER |
3,790 |
|||
|
8 SHARED DISPOSITIVE POWER |
0 |
|||
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,790 |
|||
|
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] |
|||
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% |
|||
|
12 |
TYPE OF REPORTING PERSON (See Instructions) IA |
|||
|
CUSIP No 293904108 |
13G |
Page 5 of 14 Pages |
|
1 |
NAMES OF REPORTING PERSONS |
|||
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] |
|||
|
3 |
SEC USE ONLY |
|||
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER |
0 |
||
|
6 SHARED VOTING POWER |
64 |
|||
|
7 SOLE DISPOSITIVE POWER |
0 |
|||
|
8 SHARED DISPOSITIVE POWER |
0 |
|||
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 64 |
|||
|
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] |
|||
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% |
|||
|
12 |
TYPE OF REPORTING PERSON (See Instructions) IA |
|||
|
CUSIP No 293904108 |
13G |
Page 6 of 14 Pages |
|
1 |
NAMES OF REPORTING PERSONS |
|||
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] |
|||
|
3 |
SEC USE ONLY |
|||
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER |
0 |
||
|
6 SHARED VOTING POWER |
5,600 |
|||
|
7 SOLE DISPOSITIVE POWER |
0 |
|||
|
8 SHARED DISPOSITIVE POWER |
5,600 |
|||
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,600 |
|||
|
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] |
|||
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% |
|||
|
12 |
TYPE OF REPORTING PERSON (See Instructions) IA |
|||
|
CUSIP No 293904108 |
13G |
Page 7 of 14 Pages |
|
1 |
NAMES OF REPORTING PERSONS |
|||
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] |
|||
|
3 |
SEC USE ONLY |
|||
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER |
2,468,882 |
||
|
6 SHARED VOTING POWER |
0 |
|||
|
7 SOLE DISPOSITIVE POWER |
2,468,882 |
|||
|
8 SHARED DISPOSITIVE POWER |
0 |
|||
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,468,882 |
|||
|
10 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] |
|||
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% |
|||
|
12 |
TYPE OF REPORTING PERSON (See Instructions) BD, IA |
|||
Item 1(a). Name of Issuer:
Enzo Pharmaceuticals Inc
Item 1(b). Address of Issuer’s Principal Executive Offices:
685 Route 202/206
Att: General Counsel
Bridgewater, NJ 08807
Item 2(a). Name of Person Filing:
|
Bank of America Corporation |
|
Bank of America, NA |
|
Columbia Management Advisors, LLC |
|
Banc of America Investment Advisors, Inc. |
|
IQ Investment Advisors LLC |
|
Merrill Lynch, Pierce, Fenner & Smith, Inc. |
Item 2(b). Address of Principal Business Office or, if None, Residence:
Bank of America Corporation has its principal business office at 100 North Tryon Street, Floor 25, Bank of America Corporate Center, Charlotte, NC 28255.
Item 2(c). Citizenship:
|
Bank of America Corporation |
Delaware |
|
Bank of America, NA |
United States |
|
Columbia Management Advisors, LLC |
Delaware |
|
Banc of America Investment Advisors, Inc. |
Delaware |
|
IQ Investment Advisors LLC |
Delaware |
|
Merrill Lynch, Pierce, Fenner & Smith, Inc. |
Delaware |
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
293904108
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c),
Check Whether the Person Filing is a:
|
(a) |
[ ] Broker or dealer registered under Section 15 of the Exchange Act. |
|
(b) |
[ ] Bank as defined in Section 3(a)(6) of the Exchange Act. |
|
(c) |
[ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act. |
|
(d) |
[ ] Investment company registered under Section 8 of the Investment Company Act. |
|
(e) |
[ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). |
|
(f) |
[ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). |
|
(g) |
[X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). |
|
(h) |
[ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. |
|
(i) |
[ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. |
|
(j) |
[ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). |
If this statement is filed pursuant to Rule 13d-1(c), check this box. [ ]
Item 4. Ownership:
With respect to the beneficial ownership of the reporting person, see Items 5 through 11 of the cover pages to this Schedule 13G, which are incorporated herein by reference.
Item 5. Ownership of 5 Percent or Less of a Class:
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
Item 6. Ownership or More than Five Percent on Behalf of Another Person:
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company or Control
Person:
With respect to the beneficial ownership of the reporting person, see Items 5 through 11 of the cover pages to this Schedule 13G, which are incorporated herein by reference.
Item 8. Identification and Classification of Members of the Group:
Not Applicable.
Item 9. Notice of Dissolution of Group:
Not Applicable.
Item 10. Certification:
By signing below each of the undersigned certifies that, to the best of such undersigned’s knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 02, 2010
Bank of America Corporation
Bank of America, N.A.
By: /s/ Angelina L. Richardson
_____________________
Angelina L. Richardson
Vice President
Columbia Management Advisors, LLC
By: /s/ Robert McConnaughey
_____________________
Robert McConnaughey
Managing Director
Banc of America Investment Advisors, Inc.
By: /s/ Jeffrey Cullen
__________________
Jeffrey Cullen
Vice President
IQ Investment Advisors LLC
By: /s/ Robert Zakem
_____________________
Robert Zakem
Chief Compliance Officer
Merrill Lynch, Pierce, Fenner & Smith, Inc.
By: /s/ Robert Shine
_____________________
Robert Shine
Attorney-In-Fact
Exhibit 99.1
EXHIBIT 99.1 - JOINT FILING AGREEMENT
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the
completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
In accordance with Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of to such a statement on Schedule 13G with respect to the common stock of beneficially owned by each of them. This Joint Filing Agreement shall be included as an exhibit to such Schedule 13G.
Dated: February 02, 2010
Bank of America Corporation
Bank of America, N.A.
By: /s/ Angelina L. Richardson
_____________________
Angelina L. Richardson
Vice President
Columbia Management Advisors, LLC
By: /s/ Robert McConnaughey
_____________________
Robert McConnaughey
Managing Director
Banc of America Investment Advisors, Inc.
By: /s/ Jeffrey Cullen
__________________
Jeffrey Cullen
Vice President
IQ Investment Advisors LLC
By: /s/ Robert Zakem
_____________________
Robert Zakem
Chief Compliance Officer
Merrill Lynch, Pierce, Fenner & Smith, Inc.
By: /s/ Robert Shine
_____________________
Robert Shine
Attorney-In-Fact